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Chitosan encapsulation modulates 
the effect of capsaicin on the tight 
junctions of MDCK cells
M. Kaiser1, S. Pereira1, L. Pohl2, S. Ketelhut2, B. Kemper2, C. Gorzelanny3, H.-J. Galla4, 
B. M. Moerschbacher1 & F. M. Goycoolea1
Capsaicin has known pharmacological effects including the ability to reversibly open cellular tight 
junctions, among others. The aim of this study was to develop a strategy to enhance the paracellular 
transport of a substance with low permeability (FITC-dextran) across an epithelial cell monolayer 
via reversible opening of cellular tight junctions using a nanosystem comprised by capsaicin and of 
chitosan. We compared the biophysical properties of free capsaicin and capsaicin-loaded chitosan 
nanocapsules, including their cytotoxicity towards epithelial MDCK-C7 cells and their effect on the 
integrity of tight junctions, membrane permeability and cellular uptake. The cytotoxic response of 
MDCK-C7 cells to capsaicin at a concentration of 500 μM, which was evident for the free compound, 
is not observable following its encapsulation. The interaction between nanocapsules and the 
tight junctions of MDCK-C7 cells was investigated by impedance spectroscopy, digital holographic 
microscopy and structured illumination fluorescence microscopy. The nanocapsules modulated 
the interaction between capsaicin and tight junctions as shown by the different time profile of 
trans-epithelial electrical resistance and the enhanced permeability of monolayers incubated with 
FITC-dextran. Structured illumination fluorescence microscopy showed that the nanocapsules were 
internalized by MDCK-C7 cells. The capsaicin-loaded nanocapsules could be further developed as drug 
nanocarriers with enhanced epithelial permeability.
Many animal tissues are covered with sheets of epithelial or endothelial cells that are connected via 
proteinaceous tight junctions to create a network. These networks play a key role in the mechanical 
properties of tissues and also facilitate protection against pathogens1,2. Drugs must overcome this type of 
biological barrier to reach their target tissues and exert therapeutic effects. Many synthetic nanoparticle 
formulations for targeted drug delivery have been described, but researchers have focused more recently 
on biologically-derived materials such as polysaccharides, proteins and plant-derived natural compounds 
as components of nanoformulations that are fully biodegradable, biocompatible and nonimmunogenic, 
therefore providing attractive candidates for the development of innovative therapeutic delivery strate-
gies3.
Chitosan is a natural aminopolysaccharide comprising glucosamine and N-acetyl glucosamine units. 
This biopolymer is widely used for the development of biomedical nanoformulations and shows diverse 
biological activities towards mammalian cells, including mucoadhesion4, the ability to condense and 
transport oligonucleotides5, and adjuvant activity6. Chitosan in solution or in the form of nanoparticles 
can also influence the integrity of tight junctions, opening them in vitro7–14 and in vivo13 to achieve 
enhanced paracellular permeability.
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Capsaicin is the pungent vanilloid compound in spicy chili peppers that in mammals is known to 
interact with the TRPV1 receptor, an ion channel responsible for heat sensing15. Capsaicin has numer-
ous therapeutic applications including the regulation of body temperature, the treatment of chronic 
pain and the treatment of obesity16. At a cellular level, capsaicin causes the reversible opening of tight 
junctions17,18, and the molecular basis of this phenomenon was recently investigated in MDCK cells19. 
However, the administration of capsaicin is not always feasible due to its pungency, cytotoxicity at high 
concentrations20, and sparing solubility in water21. Several studies have been conducted to incorporate 
capsaicin into nanoformulations in an attempt to make it more compatible with aqueous physiological 
environments22–24.
Colloidal nanocapsules with an oily core and a chitosan shell have been investigated as potential 
nanocarriers for transmucosal drug delivery25. These systems assemble by spontaneous emulsification 
26,27 and are versatile because they can carry both lipophilic and hydrophilic macromolecules26,28–32.
The aim of the present study was to develop a nanocarrier system based on chitosan nanocapsules to 
attenuate the adverse properties of free capsaicin (cytotoxicity and sparing solubility) while preserving 
its ability to modulate tight junctions. This approach should enhance the paracellular transport of a 
co-administered substance with low permeability as an innovative design for a drug carrier. We compared 
the physicochemical and biological activities of free capsaicin and capsaicin-loaded nanocapsules using 
epithelial MDCK-C7 cells as a model of tight junction integrity with strong barrier properties33,34. We 
carried out cytotoxicity assays and monitored changes in tight junction and barrier properties using dif-
ferent forms of microscopy and automatic impedance spectroscopy35. We found that in capsaicin-loaded 
nanosystems the cytotoxic response of MDCK-C7 cells to capsaicin is not observable at a concentration 
of 500 μM. Furthermore, the effect of capsaicin on tight junctions is modulated by encapsulation, without 
affecting its ability to enhance paracellular permeability for macromolecules.
Results
Nanocapsules and nanoemulsions have distinct physicochemical properties. The size, zeta 
potential and capsaicin-association efficiency of the nanoformulations are presented in Table  1 and 
agree with previously reported values26. The Z-average diameter of each formulation ranged from 
~160 to ~260 nm, representing a polydispersity index (PDI) of ~0.1 to ~0.2. The nanocapsules had a 
strongly positive zeta potential (~+60 mV) and strong capsaicin-association efficiency (~92%) whereas 
the uncoated nanoemulsions lacking chitosan had a strongly negative zeta potential (~–80 mV) and 
weaker capsaicin-association efficiency (~50%). Fig.  1a,b show representative transmission electron 
microscopy (TEM) images of the formulations, both of which have a spherical morphology with sizes 
within the range determined by dynamic light scattering with non-invasive back scattering (DLS-NIBS) 
(Table 1). TEM images of the nanocapsules revealed a core-shell structure including a thin surface with 
irregular topography (Fig.  1b). Figure  1c shows the time-evolution average size and polydispersity 
index (PDI) measurements of the nanocapsules incubated in Dulbecco’s modified Eagle’s cell culture 
medium (DMEM) with and without supplements. The size and PDI remained constant in both environ-
ments for 24 h, in agreement with our previous studies of chitosan nanocapsules26. An in vitro capsaicin 
release assay is shown in Fig. 1d. Capsaicin release into the cell culture medium followed a near-linear 
pattern in both formulations. After 12 h, the nanoemulsion released a greater amount of capsaicin into 
the medium (~40 μM, ~8%) compared to the nanocapsules (~20 μM, ~4%) but there was greater varia-
bility between replicates in the nanoemulsions as indicated by the larger error bars. Both release profiles 
(inset in Fig. 1d) fitted to the linearized functions (Eq. 1, see methods section) in a double logarithmic 
plot (R2 ≥ 0.99). The derived n slopes for the release of capsaicin from the nanoemulsions and nanocap-
sules were 0.82 ± 0.01 and 1.44 ± 0.05, respectively.
Nanoformulations are less toxic towards MDCK-C7 cells than free capsaicin. We inves-
tigated the influence of different concentrations of free capsaicin and the two nanoformulations and 
their constituents on the viability of MDCK-C7 cells, initially using an 3-(4,5-dimethylthiazol-2-yl)-2, 
5-diphenyltetrazolium bromide (MTT) assay to measure metabolic activity. Increasing concentrations 
of free capsaicin were evaluated over an incubation period of 3 h (Fig. 2a). A sharp drop in relative cell 
Nanoformulation Size (nm) PDI
Zeta 
potential 
(mV)
Association 
efficiency (%)
Loading 
efficiency  
(% w/w)
Loaded NC 261 ± 32 0.1 ± 0.03 +64 ± 3 92 ± 2 6.5 ± 0.14
Unloaded NC 196 ± 7 0.2 ± 0.03 +66 ± 2 —
Loaded NE 164 ± 8 0.2 ± 0.02 –82 ± 8 50 ± 23 3.8 ± 1.75
Unloaded NE 167 ± 9 0.2 ± 0.05 –79 ± 3 —
Table 1. Physicochemical properties of chitosan-coated nanocapsules (NC) and nanoemulsions (NE) with or 
without capsaicin (10 mM).
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Figure 1. Representative TEM images of (a) nanoemulsions and (b) nanocapsules. (c) Evolution of diameter 
(bars) and average polydispersity index (PDI, line) of nanocapsules during incubation in DMEM cell culture 
medium (37 °C) with (black) and without (gray) supplements. (d) In vitro capsaicin release in MEM cell 
culture medium (37 °C) with a universal concentration of 500 μM capsaicin in all formulations. Data are 
mean values ± SD (n = 3). The inset shows the double logarithmic representation of the data.
Figure 2. Cytotoxicity of different formulations against MDCK-C7 cells in 96-well plates determined using 
the MTT assay. (a) Relative cell viability following treatment with free capsaicin at increasing concentrations. 
Absolute concentrations are shown on the lower x-axis and concentrations per cultivated surface area are 
shown on upper x-axis. (b) Relative cell viability following treatment with the different nanoformulations or 
their constituents at a universal concentration of 500 μM capsaicin. For all experiments, cells were incubated 
for 3 h. Mean values ±SD. Statistical test: Kruskal-Wallis test (n = 3, ** p < 0.01, **** p < 0.0001). NC = 
nanocapsules; NE = nanoemulsion.
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viability (from ~90% to ~10%) was observed over a narrow range of concentrations (~300 to ~350 μM) and 
this difference was statistically significant compared to the untreated control (p < 0.0001, Kruskal-Wallis 
test). At lower concentrations, the measuring errors (~20%) were more distinct than those observed 
within the cytotoxic concentration range. The cytotoxicity of the nanoformulations is shown in Fig. 2b, 
with a free capsaicin control included in the same panel for clarity. All formulations were tested at the 
same concentration of capsaicin (500 μM) and the treatments with loaded and unloaded nanoformu-
lations were applied at the same carrier concentrations. The loaded nanoformulations did not signifi-
cantly reduce cell viability compared to their unloaded counterparts at the same carrier concentrations. 
However, the chitosan polymer alone in solution at the same concentration used for the preparation of 
the nanoformulations caused a significant reduction in relative cell viability. The unloaded nanocapsules 
also had a small but significant impact on cell viability.
We also estimated the cytotoxicity of the formulations by taking impedance measurements of capac-
itance (CCL) in MDCK-C7 cell monolayers grown on a porous filter membrane. CCL has been used as 
indicator of cell viability in various experimental setups in previous studies36. Fig. 3a shows CCL meas-
urements at the 3 and 24 h time points as a function of the dose of free capsaicin. The CCL begins to 
increase after 3 h at a concentration of 1000 μM, and after 24 h the same effect is also induced by 750 μM 
capsaicin. The all-or-nothing cytotoxicity response revealed by the CCL measurements is similar to that 
observed in the MTT assay, although it occurs at a ~3-fold higher critical concentration (when compared 
after incubation for 3 h). Taking into account the cultivated surface areas in the two assays, both methods 
indicate that a capsaicin concentration of ≥900 μM/cm2 reduces cell viability significantly. Fig. 3b shows 
the CCL measurements for the nanoformulations and their constituents with a constant a capsaicin con-
centration of 500 μM. No change in cell viability was observed in any of the treatments after 3 or 24 h.
Loading nanoformulations with capsaicin increases their impact on trans-epithelial electrical 
resistance. Figure  4a shows the time course of relative trans-epithelial electrical resistance (TEER) 
induced by increasing concentrations of capsaicin, whereas Fig.  4(b–d) show the comparative effect of 
the nanoformulations and some of their individual components. For clarity, the three latter plots show 
TEER values over time and are compared to the TEER behavior of the untreated control and free cap-
saicin at a concentration of 500 μM.
The free capsaicin plot (Fig. 4a) shows how the TEER profile depends on the concentration of cap-
saicin. Immediately after the addition of capsaicin, there was a sudden increase in TEER that peaked 
during the first ~20 min. This effect increased up to a concentration of 500 μM where it reached its max-
imum, and higher concentrations reduced the magnitude of this effect. After longer incubation times 
(up to 5 h), TEER decreased in a capsaicin dose-dependent manner. When considered over the entire 
time range, statistically significant differences in TEER values compared to the untreated control were 
observed at concentrations ≥500 μM (p < 0.0001, Friedman test). Approaching this concentration, the 
TEER curves showed two minima within the time ranges ~4-5 h and ~10–12 h, resembling a widened 
W shape, and recovered to approximately the original value after 24 h. If the concentration of capsaicin 
exceeded 500 μM, the cells were no longer able to recover to their original TEER value after 24 h, and 
at even higher doses of capsaicin the TEER values flattened out to zero. Close inspection of the traces 
representing the recovered cell monolayers revealed that the TEER values slightly exceeded their starting 
values after 24 h.
Figure 3. Capacitance measurements for cells grown on Transwell filters. (a) Normalized capacitance 
following treatment with free capsaicin at increasing concentrations. (b) Normalized capacitance following 
treatment with different nanoformulations or their constituents at a universal concentration of 500 μM 
capsaicin. Normalized capacitance is shown relative to the control for 3 h (black bars) and 24 h (gray bars) 
after the addition of capsaicin. Data are mean values ±SD (n = 3). NC = nanocapsules; NE = nanoemulsion.
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The corresponding TEER plot for the nanocapsules is shown in Fig. 4b. The unloaded nanocapsules 
induced a slight but significant decline in TEER (p ≤ 0.0001, Friedman test) after 2 h and between ~7 and 
~18 h. The loaded nanocapsules showed an attenuated effect compared to the free capsaicin trace at the 
same concentration (p ≤ 0.0001, Friedman test). A close inspection of both traces showed that the initial 
increase in TEER was not as distinct as that observed in response to free capsaicin. This was followed by 
a sustained decline in TEER to reach a plateau. The first trough, which was observed in the free capsaicin 
trace at ~4 h, was not present in the nanocapsule trace, but a second decline began after ~5 h and reached 
a minimum after ~8 h. This was comparable to the second depression observed in the free capsaicin trace 
(minimum at ~12 h) albeit slightly earlier. The normalized minimum TEER values of the nanocapsules 
were not as extreme as those observed for free capsaicin. The TEER values in both the nanocapsule and 
free capsaicin treatments then recovered to their initial levels after 24 hours.
The TEER for the nanoemulsions is plotted in Fig.  4c. The unloaded nanoemulsions behaved in a 
similar manner to the unloaded nanocapsules, with only a moderate TEER effect. There was a small 
and statistically non-significant decline after 2 h (p > 0.05, Friedman test). The loaded nanoemulsions 
caused similar effect as the loaded nanocapsules (p ≤ 0.0001, Friedman test) and the intensity of the TEER 
depression was similar to that induced by free capsaicin.
The effect of the chitosan polymer on TEER is shown in Fig.  4d. The polymer induced a ~10% 
decline in TEER during the first ~10 h which was not statistically significant (p > 0.05, Friedman test), and 
beyond this point TEER recovered to the original value. The behavior of the physical blend of capsaicin 
and chitosan therefore differed from that of the capsaicin-loaded nanoformulations. The attenuation 
effect at the early stage of the experiment was still evident but the overall reduction in TEER was more 
pronounced (p ≤ 0.0001, Friedman test).
Free capsaicin and capsaicin-loaded nanocapsules trigger the prolonged opening of tight 
junctions. Figure  5 shows representative quantitative phase images of MDCK-C7 cell monolayers 
obtained with digital holographic microscopy (DHM) at several time points following treatment with 
50 μM capsaicin, empty nanocapsules or capsaicin-loaded nanocapsules, plus untreated controls for com-
parison. The appearance of dark spots in the images (see arrows) indicated that tight junctions started 
opening 9 h after treatment with capsaicin. This effect became more pronounced after 17 h and persisted 
for even longer (data not shown). In contrast, no such spots were observed in the untreated control. Dark 
spots, indicating tight junction opening, were also observed when the cells were treated with nanocap-
sules. Interestingly, there was a near immediate response when cells were incubated with the unloaded 
nanocapsules whereas the capsaicin-loaded nanocapsules had a more pronounced effect on the tight 
Figure 4. Impedance spectroscopy measurements to determine TEER. The normalized TEER relative 
to the control is shown over time: (a) Increasing concentrations of free capsaicin; (b) chitosan coated 
systems, (c) uncoated systems; (d) chitosan polymer. In (b), (c) and (d) the nanoformulations are 
compared with the behavior of free capsaicin. The nanoformulations an their constituents were applied at a 
universal concentration of 500 μM capsaicin. Data are mean values ±SD (n = 3). NC = nanocapsules; NE = 
nanoemulsion.
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junctions, reaching a peak at 17 h. As observed for free capsaicin, the tight junctions did not close even 
after more than 17 h exposure to the nanocapsules (data not shown).
Free capsaicin and capsaicin-loaded nanocapsules increase the permeability of MDCK cell 
monolayers. Next we carried out a permeability assay using fluorescein isothiocyanate (FITC)-labeled 
dextran with a molecular weight of 4000 Da as a model probe. The cumulative amount of labeled dex-
tran transported across the MDCK-C7 cell monolayer increased linearly over time for all treatments 
including the control, although transport was most efficient when the cells were treated with 500 μM 
free capsaicin or the loaded nanocapsules (Fig. 6a). The variability in the amount of probe transferred 
in 24 h was lower for the loaded nanocapsules than free capsaicin, as shown by the smaller error bars. 
The unloaded nanocapsules also induced paracellular permeability, but not to the same extent as the 
loaded nanocapsules and free capsaicin. Fig. 6b shows the permeation coefficient (Papp) values calculated 
from the slopes of the curves and the enhancement of permeability is shown as a relative enhancement 
factor calculated from the Papp ratio between each treatment and the control. These calculations indi-
cated that free capsaicin and the capsaicin-loaded nanocapsules were able to increase the Papp by 2.0-fold 
and 2.2-fold respectively, compared to the control treatment, both of which were statistically signifi-
cant increases. The unloaded nanocapsules caused a non-statistically significant ~1.5-fold permeability 
increase (p > 0.05, Kruskal-Wallis test) of the cells compared to the control cells.
Loaded nanocapsules are internalized by MDCK-C7 cells. Finally, we investigated the internal-
ization of the nanocapsules by MDCK-C7 cells by three dimensional observation with structured illu-
mination fluorescence microscopy (SIFM). The recently described chitosan-affinity protein fused to a 
superfold green fluorescent protein (CAP-sfGFP) was used for the specific detection of chitosan nano-
capsules37 and the difference between attached and internalized nanocapsules was distinguished by coun-
terstaining the membrane with wheat germ agglutinin (WGA) conjugated to Texas Red. Compared to 
Figure 5. Representative DHM quantitative phase images of MDCK-C7 cell monolayers. From left to 
right: an untreated control, treatment with 50 μM free capsaicin, and treatments with unloaded and loaded 
nanocapsules (NC) at a concentration of 50 μM capsaicin, each at four different time points. Opening 
tight junctions are indicated by dark gaps in the quantitative phase contrast images (see arrows). Scale 
bar = 40 μm.
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untreated controls (Fig. 7a) only a few nanocapsules were attached to the cell surface after 2 h incubation 
(Fig. 7b) but this increased substantially after continuous co-culture for 24 h (Fig. 7c). A fraction of the 
formulation was also detected within the cells (Fig. 7d,e).
Discussion
We used a combination of physical analysis, biological assays and microscopy to compare the ability 
of free capsaicin and capsaicin-loaded nanoformulations (comprising a lecithin-based oily core with 
or without a chitosan shell) to increase the permeability of tight junctions in MDCK-C7 cell monolay-
ers. First we determined the physicochemical characteristics of the nanoformulations in terms of size, 
zeta potential, morphology, stability and capsaicin association efficiency (Table  1, Fig.  1) and found 
that our data agreed with previous reports26. We found that the chitosan-coated nanocapsules retained 
~92% of the capsaicin cargo even when loaded with 800-fold more capsaicin than in these studies (10 
vs 0.013 mM). In contrast, the nanoemulsions lacking chitosan showed a lower capsaicin-association 
efficiency (~50%), indicating that the presence of chitosan in the nanocapsule shell favors the retention 
of capsaicin during emulsification. Furthermore, we intended not to release capsaicin prior to its inter-
action with the cells but to achieve the permeability enhancement of a co-administered compound. The 
different nature of the shells in the two formulations was clearly demonstrated by the different in vitro 
capsaicin release profiles as discussed in more detail below.
We are aware that in the case of nanoemulsion only 50% of the capsaicin was associated and hence, 
we could have isolated the system to remove the free fraction of capsaicin. However, it is known that 
isolation leads to unavoidable experimental errors that might have resulted in an inaccurate estimation 
of the final concentrations of the formulation components. Moreover, since the in vitro release data 
(Fig. 1) showed only very moderate increase of released capsaicin concentration in the nanoemulsions 
with respect to nanocapsules, we opted to not isolate the formulations and preferred to keep track closely 
of the applied concentration of the components. This is consistent with recent studies by other groups 
using a similar nanosystem32. Due to the low association efficiency of capsaicin shown by the nanoemul-
sions, these systems were only used as a control for cytotoxicity and TEER studies. Nanocapsules, which 
associated more than 90% of capsaicin, were not isolated as the free fraction (~50 μM) is not sufficient 
to induce any significant effect on cytotoxicity (Fig. 2) and TEER (Fig. 4).
Cell viability studies based on MTT assays revealed that capsaicin is highly cytotoxic above a thresh-
old concentration of ~300 μM, resulting in a sharp decline in metabolic activity. This may reflect cell 
swelling due to influx of ions (probably Ca2+) through the TRPV1 receptor, as reported in HEK293 
cells15. A rapid influx of Ca2+ following exposure to capsaicin has also been reported in MDCK cells38. 
CCL measurements, which can be used as a surrogate for cytotoxicity36, showed that cell viability was 
reduced following exposure of cells to free capsaicin at a concentration of ~1000 μM for 3 h or ~750 μM 
for 24 h. Taking the surface area covered with cells in the two assays into consideration, both methods 
showed that incubation with free capsaicin at concentrations ≥900 μM/cm2 for 3 h results in a substantial 
decline in cell viability. The cytotoxic dose of capsaicin (expressed in μM/cm2) may differ between the 
assays due to the different numbers of cells used in each case, which is determined by the diameters of 
the microwells in the 96-well microtiter plate and the polycarbonate membrane inserts. In turn, this may 
reflect the possibility that capsaicin is not fully dissolved in cell culture media, but is instead present as 
a microcrystalline phase that gradually sediments onto the cell surface21. The agreement between the 
Figure 6. Permeability assay with MDCK-C7 cells and FITC-dextran (Mw = 4000 Da) following treatment 
with nanoformulations or controls at a universal concentration of 500 μM capsaicin. (a) Cumulative amount 
of dextran transported from the apical to the basolateral compartment over time after the beginning of 
treatment. (b) Permeability coefficient (Papp) derived from the slopes of the transport curves. Enhancement 
factors are calculated with respect to the control. Data are mean values ± SD. Statistical test: Kruskal-Wallis 
test (n = 4, *** p < 0.001, **** p < 0.0001). NC = nanocapsules.
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results in the two assay techniques confirms that capacitance determined by impedance spectroscopy, 
although rarely used, is nevertheless a suitable indicator of cell viability.
The TEER of cells exposed to free capsaicin showed a reversible dose-dependent effect, in good keep-
ing with previous reports19. This suggests that capsaicin could potentially be used as a natural permea-
bility enhancer to open biological barriers. The TEER data were supported by DHM quantitative phase 
microscopy images, although after treatment with capsaicin the tight junctions remained open for the 
rest of the assessment period. This discrepancy may be explained by different cell culture conditions 
during live cell imaging with DHM. The permeability of the monolayer in the presence of FITC-dextran 
was also enhanced by capsaicin but the observed effect was two orders of magnitude less potent than 
reported elsewhere for MDCK cells19. This is reasonable because the C7 clone used in our study has 
much greater tight junction integrity than other clones of the same cell line33.
In vitro release studies (Fig. 1d) showed that the profile of capsaicin release fits a linear regression in 
a double logarithmic plot that allows the n exponent in Eq. 1 (see methods section) to be calculated at 
the early stages of release. The different values of the n exponent for each system reflect differences in 
the transport of capsaicin across the two types of nanoformulations. In microspheres39,40, it is known that 
the values of the n exponent are determined by the transport mechanism. The presence of chitosan on 
the surface of the nanocapsule resulted in a different release behavior compared to the nanoemulsions 
lacking a polymeric coat. The applied model (Eq. 1, see methods section) is reported to be valid up to 
60% of the final weight of a released drug. As the R2 values were close to 1, we regarded this model 
suitable for the comparison of release profiles in both systems.
The capsaicin release profile of our formulations is distinct from that of many other nanosystems 
which release their payload in an uncontrolled manner, such as the biphasic burst like release profile 
observed for docetaxel29. The in vitro capsaicin release assays showed that both nanoformulations dis-
charged capsaicin in a monotonic profile and that most of the drug (>90%) was retained during the time 
course of the TEER measurements. This is consistent with a model in which release is controlled by 
Figure 7. SIFM images of MDCK-C7 cells treated with capsaicin-loaded chitosan nanocapsules. MDCK-C7 
cells remained untreated (a) or were treated with nanocapsules for 2 h (b) or 24 h (c). Scale bar = 10 μm. (d) 
Optical sections of the MDCK cell layer at the indicated heights (z-levels). Scale bar = 10 μm. White boxes 
mark the region of interest represented as a rendered three-dimensional vertical section (e). Nuclei were 
stained with DAPI (blue), chitosan nanocapsules were stained with CAP-sfGFP (green) and cell surfaces are 
stained with Texas Red-conjugated WGA (red).
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the partitioning of capsaicin between the components of the nanoformulations and the medium. It was 
also interesting to note that nanoemulsions released twice as much capsaicin as the nanocapsules. This 
emphasizes the role played by the polymer shell in the retention of capsaicin.
We found that, when encapsulated, capsaicin at a concentration of 500 μM can be applied without 
compromising the viability of MDCK-C7 cells compared the free molecule (Fig. 2). The chitosan shell 
itself does not appear to protect the cells directly against the effects of capsaicin because there was no 
significant difference between the nanocapsules and nanoemulsions. Significant reductions in cell viabil-
ity were also observed when the cells were exposed to unloaded nanocapsules and the chitosan polymer. 
Whether this reflects a reduction in metabolic activity or genuine cell death is yet to be determined. 
The cytotoxicity of chitosan and chitosan-based nanoparticles has been documented11,30 and has been 
suspected to be due to the interaction between positively-charged residues on the chitosan polymer with 
negatively-charged glycocalyx on the cell surface, as reported for other polycationic reagents such as 
polyethyleneimines41,42. However, it is not clear why the capsaicin-loaded nanocapsules did not cause a 
significant reduction in cell viability when their unloaded counterparts induced a slight although statis-
tically significant reduction in metabolic activity. Nevertheless, our data suggest that the encapsulation 
of capsaicin limits its cytotoxicity although the resulting changes in cell viability could not be detected 
by capacitance measurements.
The effect of the loaded and unloaded nanoformulations on the integrity of tight junctions was stud-
ied in more detail by measuring TEER behavior. The unloaded nanoemulsions had no significant impact 
on TEER, but the loaded nanoemulsions caused a substantial reduction in TEER even exceeding the 
effect caused by the loaded nanocapsules. The amount of free capsaicin present in loaded nanoemulsions 
is higher than that in the loaded nanocapsules due to the lower encapsulation efficiency. The stronger 
effect on TEER may therefore reflect the greater amount of free capsaicin in the system. The application 
of chitosan polymer solution caused a reduction in TEER consistent with previous studies in which chi-
tosan solutions were applied to monolayers of Caco-2 cells9. Our data show unequivocally that capsaicin 
and capsaicin-loaded nanoformulations at the applied concentrations can cause the reversible disruption 
of tight junctions. Furthermore, the specific time profile of this effect can be modulated by the type of 
nanoformulation, and perhaps also by chitosan alone in solution as claimed elsewhere43.
To understand the significance of the TEER data, we conducted paracellular permeability assays using 
FITC-labeled dextran as a model hydrophilic macromolecule that crosses cell layers with low efficiency 
(Fig.  6). We found that although the unloaded nanocapsules had only a minor impact on TEER, they 
were nevertheless able to increase the amount of dextran transported across the cell layer albeit not to 
a statistically significant extent. The loaded nanocapsules were able to modulate the TEER of the cells, 
indicating that capsaicin activity persists when encapsulated. The low cytotoxicity induced by capsaicin 
even at higher doses of these formulations suggests that the high association efficiency and minimal 
release ensure that only small amounts of the free drug are available. In the permeability experiments, 
the loaded nanocapsules were observed to permeate the largest amount of dextran through the cell 
monolayer suggesting that nanocapsules can deliver capsaicin in a more efficient manner than the free 
drug applied in solution.
SIFM analysis showed that the chitosan nanocapsules accumulated on the cell surface and few were 
internalized during the assessment period (Fig. 7). A few nanocapsules were already localized at the cell–
medium interface after incubation for 2 h, which matches the declining TEER values (Fig. 4b). The direct 
physical interaction between the nanocapsules and cell surface probably results in local particle enrich-
ment to the extent that the concentration of free capsaicin is sufficient to open the epithelial barrier. 
Furthermore, the close proximity of the nanocapsules and the extracellular matrix components exposed 
by the cells may promote the release of capsaicin, increasing its availability in the cellular microenviron-
ment. Mechanistic studies have to be carried out to elucidate the cellular uptake route and the intracel-
lular effect of nanoencapsulated capsaicin.
DHM quantitative phase images (Fig. 5) confirmed that tight junctions opened in response to both 
the loaded and unloaded chitosan-coated nanoformulations. Chitosan and capsaicin promoted the open-
ing of tight junctions at different time points, suggesting that different mechanisms are involved. The 
loaded nanoformulations delayed the opening of tight junctions compared to the individual effects of 
chitosan and capsaicin. A lower degree of cell stress was also observed, as shown by the less severe 
changes in morphology compared to the cells exposed to free capsaicin.
In conclusion, the nanoformulations we investigated may offer a novel strategy for the delivery of 
drugs across biological barriers using only natural compounds. Encapsulation substantially changes the 
behavior of capsaicin and higher concentrations of capsaicin can be applied as nanocapsules without 
inducing the level of cell stress caused by free capsaicin while achieving the same degree permeability. 
Further investigations will involve the co-loading of nanocapsules with capsaicin and other drugs to 
study their ability to deliver drugs across biological barriers. Our ongoing studies are currently address-
ing whether the encapsulation of capsaicin in nanoformulations also modulates its pungency.
Materials and methods
Chitosan. The sample of chitosan we used was an ultrapure biomedical grade Heppe 70/5 (Batch 
No. 212-140311-02) purchased from HMC+ GmbH (Halle/Saale, Germany). The molecular weight of 
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17,600 Da was determined by measuring its intrinsic viscosity in 0.3 M acetic acid/0.2 M sodium acetate 
at 25 °C44 and the degree of acetylation of 32.4% was determined by 1H NMR spectroscopy. Ultrapure 
MilliQ water was used throughout.
Dissolution of capsaicin. Capsaicin (from Capsicum sp. 96%, Sigma-Aldrich, Steinheim, Germany) 
was dissolved in ethanol at a concentration of 24 mg/ml. For the cell culture experiments, this capsaicin 
stock was further diluted with modified Eagle’s medium (MEM) in a 50-ml Falcon tube. The medium 
was added with a pipette by dripping it gently along the wall of the inclined tube. As soon as the MEM 
mixed with the capsaicin solution the mixture became slightly turbid. These samples were immediately 
used without shaking. This protocol ensured reproducible results in the biological assays.
Preparation of the nanoformulations. The chitosan-coated nanocapsules were prepared as pre-
viously described with slight modifications26. Briefly, 400 μl of a 100 mg/ml ethanolic lecithin solution 
(Epikuron 145 V, Cargill texturing solutions Deutschland GmbH & Co. KG, Hamburg, Germany) was 
mixed with 530 μl of the capsaicin stock solution described above (24 mg/ml). This was supplemented 
with 125 μl Miglyol 812 N (Sasol GmbH, Witten, Germany) and 9.5 ml acetone. The organic solution was 
immediately poured into 20 ml aqueous chitosan (0.5 mg/ml in 5% stoichiometric excess of 5 M HCl). 
The milky mixture was concentrated in a rotavapor (Büchi R-210, Büchi Labortechnik GmbH, Essen, 
Germany) at 50 °C until 3.5–4.0 ml remained and the volume was topped up to 4.0 ml with milliQ water 
if necessary to yield a final capsaicin concentration of ~10 mM. The nanoemulsions were prepared using 
the same procedure but without including chitosan. Unloaded nanocapsules and nanoemulsions were 
prepared by replacing the capsaicin solution with ethanol.
Size and zeta potential. The size distribution of the nanoformulations was determined by dynamic 
light scattering with non-invasive back scattering (DLS-NIBS) with a measurement angle of 173°. The 
zeta potential was measured by mixed laser Doppler velocimetry and phase analysis light scattering 
(M3–PALS). A Malvern Zetasizer NanoZS (Malvern Instruments Ltd., Worcestershire, UK) fitted with a 
red laser light (λ = 632.8 nm) was used for both methods. The samples were diluted 1:50 in water before 
measurement.
TEM. The ultrastructure of the nanoformulations was investigated by TEM using a CM12 instrument 
(Philips, Eindhoven, Netherlands). The samples were mounted on copper grids coated with Formvar® 
and stained with 10 mg/ml research grade uranyl acetate (Serva Electrophoresis GmbH, Heidelberg, 
Germany).
High-performance liquid chromatography (HPLC) with UV detection. HPLC-UV was carried 
out using a Jasco HPLC system (Jasco GmbH, Gross-Umstadt, Germany) comprising a three-line degas-
ser (DG-2080-53), a ternary gradient unit (LG-2080-02S), a semi-micro HPLC pump (PU-2085Plus), an 
autosampler (X-LC™ 3159AS), an intelligent column thermostat (CO-2060 Plus) equipped with a Kinetex 
C-18 reversed phase column (2.6 μm, C18, 50 × 2.1 mm, S/N 539947-37; Phenomenex, Torrance, USA) 
and a UV/Vis detector (X-L™ 3075UV). A mixture of 35% water and 65% acetonitrile was used in iso-
cratic mode as the mobile phase at a flow rate was 0.15 ml/min. Capsaicin was detected at λ  = 228 nm.
Association efficiency. The nanoformulations were partitioned by ultracentrifugation (Mikro 220 R, 
Hettich GmbH & Co. KG, Tuttlingen, Germany) at 16,000 rpm for 1 h at 15 °C, and the capsaicin content 
of the subnatant was determined by HPLC as described above. The association efficiency was calculated 
as the difference between the total amount of capsaicin incorporated in the formulation and the amount 
present in the subnatant.
In vitro capsaicin release assay. An 800-μl aliquot of each formulation was transferred to a dialysis 
tube (Pure-a-lyzer Maxi 0.1–3.0 ml, Mw cut-off = 6 kDa, Sigma-Aldrich GmbH, Steinheim, Germany) 
and placed in a glass beaker containing 79.2 ml MEM previously equilibrated at 37 °C in an incubator. 
Every hour, a 500-μl aliquot of medium was removed and replaced with the same volume of MEM. The 
capsaicin content of the aliquots was determined by HPLC as described above. The transport of capsaicin 
from the nanoformulations into the medium was analyzed by fitting the data to the empirical equation39:
/ = ( )∞M M kt 1t
n
where Mt is the mass of capsaicin released at time t. The parameter M∞ represents the total mass of 
capsaicin to be released and k is a constant that depends on the structural characteristics of the nanofor-
mulation and the solvent/material interactions.The exponent n is used to indicate the type of diffusion.
Cell culture. Mandin Darby Canine Kidney (MDCK) cells clone C733 were cultured in 75 cm2 
flasks using MEM supplemented with 10% fetal bovine serum, 1% L-glutamine (200 mM) and 1% 
penicillin-streptomycin (10000 units penicillin, 10000 units streptomycin in 0.9% NaCl). The cultures were 
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maintained in a humid atmosphere at 37 °C with 5% CO2 (Sanyo MCO-19AIC, Panasonic Biomedical 
Sales Europe BV, AZ Etten Leur, Netherlands). Cells from passages 22–34 were used for all experiments, 
which were carried out as independent triplicates on different days. After reaching microscopic conflu-
ence, the cells were washed with 10 ml phosphate buffered saline (PBS) and trypsinized with 10 ml 0.05% 
trypsin in EDTA (1x) buffer. After detachment, 10 ml of MEM was added to the trypsin buffer. The cell 
suspension was centrifuged at 1000 rpm for 5 min (Rotina 420 R, Hettich GmbH, Tuttlingen, Germany). 
The excess of medium was removed and the cell pellet was resuspended in 1 ml MEM. A 10-μl aliquot 
of the cell suspension was diluted with 90 μl trypan blue and the number of cells was counted with an 
improved Neubauer chamber before seeding. The cells were subcultured by splitting at a ratio of 1:10.
3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. The cytotoxicity 
of the nanoformulations and components was evaluated using an MTT assay45. Briefly, 100 μl of cell 
suspension was transferred to each well of a 96-well tissue culture plate (~104 cells per well or ~105 cells/
ml) and allowed to attach for 24 h. The cells were washed twice with supplement-free MEM before the 
sample was added and the cells were incubated for 3 h. The samples were removed and replaced with 
100 μl supplement-free MEM. We prepared an MTT solution in PBS with a concentration of 5 mg/ml 
of thiazolyl blue tetrazolium bromide and added 25 μl to each well. After 4 h, the medium was again 
removed and the dye was dissolved in DMSO. After orbital shaking at 300 rpm for 15 min, the absorb-
ance was measured at λ = 570 nm in a microplate reader (Safire, Tecan AG, Salzburg, Austria). Relative 
viability values were calculated by dividing individual viabilities by the mean of the control. We used 4% 
Triton X-100 in PBS as a positive control.
Electrical impedance measurements. The TEER and capacitance (CCL) of cell monolayers were 
measured using an automated CellZscope® instrument (nanoAnalytics, Münster, Germany). Approximately 
1.5 ml of cell culture medium was transferred to the basolateral chamber of 12-mm Transwell Permeable 
Supports with 0.4-μm pore polycarbonate membrane inserts (Corning Inc., New York, USA). A 500-μl 
aliquot of MDCK cells in suspension was then seeded onto the membrane supports (~105 cells per 
well) and allowed to grow for 4 days. Approximately 24 h before the experiment, every well was filled 
with 1.5 ml supplement-free MEM and the cell culture medium of the supports was replaced in the 
apical compartment with supplement-free MEM. The supports were transferred into the instrument and 
allowed to acclimate. After reaching a constant resistance of at least 5000 Ω cm2 the experiment was ini-
tiated by replacing 250 μl of the medium in the apical chamber with the sample dissolved in measuring 
medium at double the desired concentration. The resistance and capacitance was measured continuously 
for 24 h. The normalized TEER and capacitance values were calculated using Eq. 2:
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Permeability assay. Cells were seeded at a density of 2.5 × 104 cells per well on Transwell Permeable 
Supports as described above and provided with MEM lacking phenol red but supplemented like the 
medium used for the regular cell culture. The same volumes were used for the apical and basolateral 
chambers as described above. The cells were cultured for 4 days to develop confluent monolayers and 
the medium was replaced with serum-free transport medium and equilibrated overnight. The next day, 
TEER was measured in the Transwells. Only filters with an electrical resistance >5000 Ω cm2 were used. 
For these filters, half of the medium in the apical chamber was replaced with the same medium contain-
ing double the concentration of sample and 37.5 μl 50 mg/ml FITC-dextran, Mw 4000 Da, FITC:glucose 
1:250; Sigma-Aldrich GmbH, Steinheim, Germany). Aliquots of medium (100 μl) were taken from the 
basolateral chamber after 1, 3, 5, 7, 9 and 24 h and replaced with fresh medium. The aliquots were 
transferred to 96-well plates (UV star black f-bottom, chimney well, μ clear; Greiner Bio-one GmbH, 
Frickenhausen, Germany) and fluorescence (λex = 485 nm, λem = 520 nm) was measured in the microplate 
reader described above. Papp was calculated using Eq. 3 as previously described46:
= × ×
( )
P V dC
dt AC
1
3app r 0
where Vr (cm3) represents the volume of the acceptor compartment, dC/dt (M/s) represents the slope of 
the cumulative concentration of the compound in the acceptor chamber over time, A (cm2) represents 
the membrane surface area and C0 (M) is the initial concentration of the compound in the donor cham-
ber. The experiment was carried out as four independent replicates.
Digital holographic microscopy (DHM). Cells were seeded on microscope dishes (ibidi μ-Dish 
with glass lid, ibidi GmbH, Munich, Germany) in MEM at a density of 2.1 × 105 cells/dish and were 
allowed to attach overnight. The following day the medium was replaced with MEM lacking supplements 
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but containing the nanoformulations in 20 mM HEPES buffer. Quantitative imaging of MDCK cells 
by label-free DHM was carried out using an inverted microscope (iMIC, Till Photonics, Gräfelfing, 
Germany) with an attached DHM module47, and an incubator (Solent Scientific Ltd., Segensworth, 
UK) to ensure temperature stability. This instrument was used for bright-field imaging and quantitative 
DHM phase-contrast imaging. The coherent light source for the capture of digital holograms was a 
frequency-doubled neodymium-doped yttrium aluminum garnet (Nd:YAG) laser (Compass 315 M-100, 
Coherent, Lübeck, Germany, λ = 532 nm). Digital holograms of single cells were recorded continu-
ously every 3 min using a 20x microscope lens (Zeiss LD Acroplan 20x/0.4 Korr). Quantitative phase 
images were reconstructed from the digitally-captured holograms by spatial phase shifting as previously 
described48,49 with custom-built software. Three independent measurements were taken in each experi-
ment. Additional cell viability assays simulating the cell culture conditions during DHM analysis (includ-
ing HEPES buffer but without a CO2-enriched atmosphere) showed a greater cytotoxic effect of capsaicin 
starting at a concentration of ~200 μM (see Supporting Information). We therefore chose a concentration 
of 50 μM capsaicin for these experiments.
Structured illumination fluorescence microscopy (SIFM). MDCK cells were seeded on glass 
slides and cultivated to confluence as described above. The cells were treated with 250 μM chitosan 
nanocapsules in supplement-free medium for 2 or 24 h. Prior to staining, the cells were fixed at 4 °C for 
30 min in HEPES-buffered Ringer’s solution (10 mM HEPES, 5 mM glucose, 1 mM CaCl2, 1 mM MgCl2, 
5 mM KCl, 140 mM NaCl) containing 4% paraformaldehyde. The cells were then permeabilized with 
incubation buffer (HEPES-buffered Ringer’s solution, supplemented with 0.3% Triton X-100 and 0.1% 
bovine serum albumin) and nonspecific staining was blocked with incubation buffer supplemented with 
2% bovine serum albumin. Chitosan nanocapsules were stained with 100 μg/ml CAP-sfGFP and cell 
surfaces were counterstained with 2.5 μg/ml Texas Red conjugated to WGA (Life Technologies GmbH, 
Darmstadt, Germany). Nuclei were stained with 500 ng/ml 2-(4-amidinophenyl)-6-indolecarbamidine 
dihydrochloride (DAPI; Sigma-Aldrich GmbH, Steinheim, Germany). Coverslips were mounted in 
DABCO-Mowiol (Sigma-Aldrich GmbH, Steinheim, Germany) and analyzed by SIFM using an inverted 
fluorescence microscope (AxioObserver.Z1, Zeiss, Jena, Germany) equipped with a structured illumina-
tion module (ApoTome, Jena, Germany). Three-dimensional rendered images of optical sections were 
calculated with ImageJ50.
Data analysis. Statistical analysis was carried out using Prism v6.0c (GraphPad Software Inc., La Jolla, 
USA). All experiments were statistically analyzed using non-parametric tests. The Kruskal-Wallis test was 
used for unpaired tests and the Friedman test was used for paired tests. All biological experiments were 
conducted at least in triplicate.
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